Please assess the completion status of the following clinical trial:

Trial Title: Fundic Gland Polyps and Proton Pump Inhibitor (PPI) Drugs

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age 18 and above.~* Able and willing to sign informed consent.~* The patient had a gastric fundic gland polyp detected on EGD that was removed and sent to pathology or patient had no fundic gland polyps on EGD but are on PPIs and will serve as controls.~Exclusion Criteria:~* Unwilling or unable to sign informed consent for the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- Fundic Gland Polyps on PPI (Type: None): Patients found to have fundic gland polyps on endoscopic evaluation that have also been prescribed and regularly take a proton pump inhibitor.
- Fundic Gland Polyp not on PPI (Type: None): Patients found to have fundic gland polyps on endoscopic evaluation that have not been prescribed a proton pump inhibitor.
- Group 3 (Control Group) (Type: None): Individuals who are prescribed proton pump inhibitor but are not found to have fundic gland polyps on endoscopic evaluation.

Based on this trial design, predict the completion outcome and termination type (if applicable).